Twice-daily radiation showed better survival and quality of life compared to once-daily radiation, easing concerns about its impact. Adding Tecentriq to chemoradiation improved quality of life and ...

Coherus Oncology's Loqtorzi has resumed growth in earnest, with Q2 2025 net revenues of $10M. Click here to find out why CHRS stock is a Buy.

JOINT BASE LEWIS-McCHORD, Washington - Soldiers from Joint Base Lewis-McChord, specifically from I Corps’ field artillery, infantry, and aviation units, participated in a Special User Demonstration ...

The Surface Transportation Board today proposed streamlining and improving reporting requirements for Class I rail carriers, including the weekly operational performance measures that serve as a ...

In experiments with mouse models of breast, pancreatic, and muscle cancers, researchers at Johns Hopkins All Children’s Hospital report new evidence that a novel means of boosting the natural immune ...

United Airlines has announced that the FAA has approved Starlink's Supplemental Type Certificate (STC) amendment for the Boeing 737-800, to include its mainline aircraft fleet ...

A new clinical trial report finds that stereotactic radiation therapy offers long-term survival outcomes comparable to surgery for patients with small, early-stage non-small cell lung cancer (NSCLC).

Riyadh’s new metro system spans 176 kilometers with 85 striking stations, blending futuristic design and tradition, carrying millions while reshaping daily travel across the capital.

Insurance providers use their expertise in risk assessment to help protect assets while offering consumers peace of mind through comprehensive coverage options. But concerns about claims severity and ...

Smart power management – APOS expands Advantest’s Smart TestCell (STC) ecosystem, which leverages advanced automation and resource management to enable smart semiconductor manufacturing. APOS ...

A new clinical trial report finds that stereotactic radiation therapy offers long-term survival outcomes comparable to surgery for patients with small, early-stage non-small cell lung cancer (NSCLC).